Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Treasury Shares: 2020-2023

Historic Treasury Shares for Therapeutics (RAPT) over the last 4 years, with Dec 2023 value amounting to $13,500.

  • Therapeutics' Treasury Shares fell 50.00% to $13,500 in Q4 2023 from the same period last year, while for Dec 2023 it was $13,500, marking a year-over-year decrease of 50.00%. This contributed to the annual value of $13,500 for FY2023, which is 50.00% down from last year.
  • According to the latest figures from Q4 2023, Therapeutics' Treasury Shares is $13,500, which was down 0.00% from $13,500 recorded in Q3 2023.
  • Over the past 5 years, Therapeutics' Treasury Shares peaked at $56,500 during Q2 2020, and registered a low of $13,500 during Q1 2023.
  • In the last 3 years, Therapeutics' Treasury Shares had a median value of $27,000 in 2022 and averaged $27,000.
  • Data for Therapeutics' Treasury Shares shows a maximum YoY plummeted of 50.00% (in 2023) over the last 5 years.
  • Therapeutics' Treasury Shares (Quarterly) stood at $56,500 in 2020, then decreased by 28.32% to $40,500 in 2021, then slumped by 33.33% to $27,000 in 2022, then tumbled by 50.00% to $13,500 in 2023.
  • Its last three reported values are $13,500 in Q4 2023, $13,500 for Q3 2023, and $13,500 during Q2 2023.